During the past decade, Hospital Universitário Walter Cantídio conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 11 clinical trials were completed, i.e. on average, 52.4% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 9 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitário Walter Cantídio" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Allergan" with 3 trials sponsored, "Institut de Recherches Internationales Servier" with 3 trials sponsored, "R-Pharm International, LLC" with 3 trials sponsored and "Hospital Israelita Albert Einstein" with 3 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitário Walter Cantídio" #1 collaborator was "OCT Clinical Trials" with 3 trials as a collaborator, "ADIR, a Servier Group company" with 2 trials as a collaborator, "Ministry of Health, Brazil" with 2 trials as a collaborator, "Quintiles, Inc." with 2 trials as a collaborator and "CMS Medical" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitário Walter Cantídio" are "Gastroparesis" (3 trials), "Rheumatoid Arthritis" (3 trials), "Autism Spectrum Disorder (ASD)" (2 trials), "Depressive Disorder, Major" (2 trials) and "Diabetes Mellitus" (2 trials). Many other conditions were trialed in "Hospital Universitário Walter Cantídio" in a lesser frequency.

Most popular intervention types in "Hospital Universitário Walter Cantídio" are "Drug" (19 trials), "Other" (3 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Etrolizumab" (3 trials), "Relamorelin" (2 trials), "Adalimumab" (1 trials) and "Adalimumab 40mg q2w" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitário Walter Cantídio" are 24 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Universitário Walter Cantídio". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Hospital Universitário Walter Cantídio, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitário Walter Cantídio, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".